Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_assertion description "[These regions harbor established oncogenes and tumor suppressors, including CCND1 (cyclin D1), MET (hepatocyte growth factor receptor), CDKN2A (cyclin-dependent kinase inhibitor 2A) and CDKN2B (cyclin-dependent kinase inhibitor 2B), as well as many other genes not previously reported to be involved in liver carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_assertion evidence source_evidence_literature NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_assertion SIO_000772 23505090 NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_assertion wasDerivedFrom befree-20140225 NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_assertion wasGeneratedBy ECO_0000203 NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.
- befree-20140225 importedOn "2014-02-25" NP878963.RA-vMZXPdIgd6I1IpRRyANQq-8Zj8jsjEsiuoPKF9GB_Q130_provenance.